Rep. Jared Moskowitz Sells UnitedHealth Group Incorporated (NYSE:UNH) Stock

Representative Jared Moskowitz (D-Florida) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on June 27th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on May 15th. The trade occurred in the Representative's "MORGAN STANLEY ACTIVE ASSETS (6)" account.

Representative Jared Moskowitz also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Cigna Group NYSE: CI on 5/15/2025.
• Purchased $1,001 - $15,000 in shares of HCA Healthcare NYSE: HCA on 5/15/2025.
• Purchased $1,001 - $15,000 in shares of Amgen NASDAQ: AMGN on 4/16/2025.
• Purchased $1,001 - $15,000 in shares of NVIDIA NASDAQ: NVDA on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Starbucks NASDAQ: SBUX on 4/10/2025.
• Sold $15,001 - $50,000 in shares of The Goldman Sachs Group NYSE: GS on 4/10/2025.
• Sold $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 4/10/2025.
• Sold $1,001 - $15,000 in shares of NextEra Energy NYSE: NEE on 4/7/2025.
• Purchased $1,001 - $15,000 in shares of Carrier Global NYSE: CARR on 4/7/2025.
• Purchased $1,001 - $15,000 in shares of Accenture NYSE: ACN on 4/7/2025.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded down $13.99 during trading on Thursday, reaching $278.52. The company's stock had a trading volume of 22,499,738 shares, compared to its average volume of 11,323,359. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a market capitalization of $252.66 billion, a P/E ratio of 11.66, a price-to-earnings-growth ratio of 1.39 and a beta of 0.45. The business has a 50 day moving average price of $301.70 and a 200-day moving average price of $428.82. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 3.17%. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 37.02%.

Wall Street Analysts Forecast Growth

UNH has been the subject of several recent research reports. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Baird R W cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. Barclays restated an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Wells Fargo & Company reaffirmed an "overweight" rating on shares of UnitedHealth Group in a research note on Friday, June 6th. Finally, Raymond James Financial lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $394.43.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP increased its position in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after purchasing an additional 319,515 shares during the last quarter. Capital International Investors raised its stake in UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after buying an additional 906,365 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $6,375,744,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director owned 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the business's stock in a transaction on Friday, May 16th. The stock was purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer directly owned 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by insiders.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida's 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027. Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida's 23rd Congressional District. He declared candidacy for the 2026 election. Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor's degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz's career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.